Reka Pataky

9PUBLICATIONS
41CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer diagnosisEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 09, 2024
Using Genomic Heterogeneity to Inform Therapeutic Decisions for Metastatic Colorectal Cancer: An Application of the Value of Heterogeneity Framework.

Reka E Pataky, Stuart Peacock, Stirling Bryan

|Oct 25, 2024
Cost-effectiveness analysis of simple hysterectomy compared to radical hysterectomy for early cervical cancer: analysis from the GCIG/CCTG CX.5/SHAPE trial.

Janice S Kwon, Helen McTaggart-Cowan, Sarah E Ferguson

|Jun 26, 2024
Real-World Safety of Niraparib for Maintenance Treatment of Ovarian Cancer in Canada.

Qi Guan, Suriya J Aktar, Reka E Pataky

|Oct 25, 2023
Direct Medical Spending on Young and Average-Age Onset Colorectal Cancer before and after Diagnosis: a Population-Based Costing Study.

Ria Garg, Eric C Sayre, Reka Pataky

|Oct 11, 2023
Real-World Cost Effectiveness of a Policy of KRAS Testing to Inform Cetuximab or Panitumumab for Third-Line Therapy of Metastatic Colorectal Cancer in British Columbia, Canada.

Reka E Pataky, Stirling Bryan, Mohsen Sadatsafavi

|Mar 28, 2023
Health Care Costs Attributable to Prostate Cancer in British Columbia, Canada: A Population-Based Cohort Study.

Wei Zhang, Daphne P Guh, Tima Mohammadi

Pageof 2

Frequent Collaborators

5 joint publications

Stuart Peacock

3 joint publications

Stirling Bryan

3 joint publications

Mohsen Sadatsafavi

3 joint publications

Dean A Regier